Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Guardant Health, Inc. (GH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 8-K Quarterly results
Docs: "Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance Q2 revenue increased 26% year over year driven by clinical volume growth of 49%"
08/01/2023 8-K Quarterly results
05/25/2023 8-K Asset disposition
Docs: "Underwriting Agreement, among Guardant Health, Inc. and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Cowen and Company, LLC and SVB Securities LLC, as representatives of the several underwriters named therein",
"Opinion of Latham & Watkins LLP"
05/09/2023 8-K Quarterly results
Docs: "Guardant Health Reports First Quarter 2023 Financial Results Q1 revenue increased 34% year over year driven by clinical volume growth of 45%"
05/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield ™ blood test"
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Guardant Health Announces Additions to Leadership Team"
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Musa Tariq joins Guardant Health board of directors"
02/23/2023 8-K Quarterly results
Docs: "Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook Q4 clinical and biopharma volumes up 41% and 24% year over year"
01/09/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results Full year clinical and biopharma volumes up 42% and 40% year over year"
12/15/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
06/21/2022 8-K Quarterly results
06/13/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
02/28/2022 8-K Quarterly results
02/23/2022 8-K Quarterly results
Docs: "Guardant Health Reports Fourth Quarter 2021 Financial Results and Provides 2022 Outlook Q4 clinical and biopharma volumes up 48% and 36% year over year"
01/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Guardant Health and Foundation Medicine Reach Settlement in Digital Sequencing Technology Litigation"
11/04/2021 8-K Quarterly results
Docs: "Guardant Health Reports Third Quarter 2021 Financial Results Achieved record revenue of $94.8 million"
10/20/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Guardant Health Appoints Myrtle Potter to its Board of Directors REDWOOD CITY, Calif.— October 20, 2021 — Guardant Health, Inc. , a leading precision oncology company, has appointed Myrtle Potter to serve on its Board of Directors. “We are very pleased to welcome Myrtle Potter to our Board of Directors as we continue to build and deliver on our mission of conquering cancer with data,” said Helmy Eltoukhy, Guardant Health Co-CEO and Chairman of the Board. “Myrtle has extensive knowledge and experience bringing world-class therapeutics to market, and her industry expertise will be invaluable as we strive to provide patients across all stages of cancer with access to the latest advancements in precision oncology.” “I am thrilled to be joining Guardant Health's Board of Directors at such a sig..."
08/05/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
06/21/2021 8-K Quarterly results
05/17/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
01/11/2021 8-K Quarterly results
01/07/2021 8-K Quarterly results
12/11/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Offer Letter, by and between Guardant Health, Inc. and Michael Bell",
"Employment Letter, by and between Guardant Health, Inc. and Derek Bertocci",
"Guardant Health Names Michael Bell as New Chief Financial Officer REDWOOD CITY, Calif. December 11, 2020 — Guardant Health, Inc. , a leading precision oncology company, has named Michael Bell as the company's new Chief Financial Officer effective January 5, 2021. Michael will succeed Derek Bertocci who has retired after successfully ushering the company through its successful transition as a public company. “I am delighted to welcome Michael Bell to our executive leadership team,” said Helmy Eltoukhy, Guardant Health CEO. “Michael is a proven business leader whose extensive experience leading the financial operations of leading clinical diagnostic and pharmaceutical companies will make a tremendous impact as we continue to position Guardant Health for the future and progress toward our goa..."
11/17/2020 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Guardant Health, Inc. Announces Proposed Convertible Senior Notes Offering",
"Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering"
11/05/2020 8-K Quarterly results
Docs: "Guardant Health Reports Third Quarter 2020 Financial Results Q3 2020 Revenue Increase of 23% Over Prior Year Period"
10/09/2020 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy